Ohminami K, Matsuoka E, Takahashi Y, Shimizu D, Okuda H
Nihon Yakurigaku Zasshi. 1984 Feb;83(2):123-32.
The present experiments were carried out to elucidate the effect of mazindol feeding on obese mice made by gold-thioglucose injection. Mazindol was added to the diet at the level of 0.5, 2, 10 mg/kg body weight. It was found that oral administration of mazindol reduced the body weight gain and perimetrial adipose tissue weights increased in GTG-obese mice. Decreased adipose tissue weights were correlated with the decreased level of size and volume of fat cells. Basal lipolytic activity and adrenaline-induced lipolysis were also significantly decreased in mazindol groups as compared to those in GTG-obese mice that were not administered mazindol. These results indicate that the weight reduction induced by mazindol administration might not be due to increase in fat mobilization. The increased level of liver and serum lipid induced by GTG-obesity was also found to be improved by mazindol. Scanning electron micrographs indicated that the villous width of the small intestine were significantly smaller in the mazindol group that those in the GTG-obese group. Sucrase and esterase activities of the small intestine were also decreased by mazindol feeding as compared to those in the GTG-obese mice. based on these results mechanisms of action of mazindol were discussed.
进行本实验以阐明喂食马吲哚对注射金硫葡萄糖制成的肥胖小鼠的影响。将马吲哚以0.5、2、10mg/kg体重的水平添加到饮食中。发现口服马吲哚可降低金硫葡萄糖诱导的肥胖小鼠的体重增加以及子宫周围脂肪组织重量。脂肪组织重量的减少与脂肪细胞大小和体积的降低相关。与未给予马吲哚的金硫葡萄糖诱导的肥胖小鼠相比,马吲哚组的基础脂解活性和肾上腺素诱导的脂解也显著降低。这些结果表明,马吲哚给药引起的体重减轻可能不是由于脂肪动员增加。还发现马吲哚可改善金硫葡萄糖诱导的肥胖所引起的肝脏和血清脂质水平升高。扫描电子显微镜照片显示,马吲哚组小肠绒毛宽度明显小于金硫葡萄糖诱导的肥胖组。与金硫葡萄糖诱导的肥胖小鼠相比,喂食马吲哚也会降低小肠的蔗糖酶和酯酶活性。基于这些结果,讨论了马吲哚的作用机制。